Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic SyndromeAlan F. List, Emmanuel C. Besa, Jason Esposito et al.|Journal of Clinical Oncology|2012Cited by 175
Iron Chelation with Deferasirox (Exjade®) Improves Iron Burden in Patients with Myelodysplastic Syndromes (MDS)Alan F. List, Emmanuel C. Besa, Maria R. Baer et al.|Blood|2008Cited by 31